Last 48 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
ICU Medical, Inc.'s quarterly P/E stands at 26.9x. EV/EBITDA has expanded 313.0% YoY to 78.1x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 4186.05 | 26.91 | — | — | 23.10 | — | — | — | — | — | — | 99.18 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.38 | 1.53 | 1.63 | 1.38 | 1.49 | 1.41 | 1.51 | 1.89 | 1.21 | 1.15 | 1.02 | 1.31 | 1.95 |
| — | +8.9% | +8.0% | -27.0% | +22.5% | +22.8% | +47.3% | +44.2% | -37.8% | -34.1% | -37.3% | -13.0% | +11.5% | |
| P/B Ratio | 1.44 | 1.54 | 1.66 | 1.39 | 1.54 | 1.71 | 1.93 | 2.17 | 1.42 | 1.26 | 1.13 | 1.38 | 2.03 |
| — | -10.2% | -14.2% | -36.0% | +8.6% | +36.4% | +70.5% | +57.3% | -29.9% | -33.3% | -37.3% | -22.7% | +7.7% | |
| P/FCF | 33.50 | 29.45 | 24.49 | 26.79 | — | 23.21 | 69.89 | 51.66 | 11.59 | 24.14 | 10.15 | 68.38 | — |
| — | +26.9% | -65.0% | -48.1% | — | -3.9% | +588.5% | -24.5% | — | -34.1% | — | — | — | |
| EV / EBITDA | 12.80 | 78.14 | 14.47 | 15.60 | 18.07 | 18.92 | 14.15 | 22.71 | 16.95 | 22.48 | 21.45 | 3.72 | 24.13 |
| — | +313.0% | +2.3% | -31.3% | +6.6% | -15.8% | -34.0% | +510.0% | -29.7% | +6.9% | -8.5% | -83.0% | +18.5% | |
| EV / EBIT | 38.90 | — | 178.57 | 63.89 | 19.19 | 82.16 | 37.30 | 154.92 | 150.15 | — | — | 94.06 | 489.67 |
| — | — | +378.7% | -58.8% | -87.2% | — | — | +64.7% | -69.3% | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
ICU Medical, Inc.'s operating margin was 2.6% in Q1 2026, down 2.1 pp QoQ and up 0.4 pp YoY. Gross margin expanded 11.9% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 38.9% | 37.4% | 37.4% | 37.9% | 34.7% | 36.1% | 34.8% | 34.8% | 32.7% | 29.2% | 33.2% | 35.0% |
| — | +11.9% | +3.7% | +7.6% | +9.0% | +6.3% | +23.6% | +4.6% | -0.7% | -3.2% | -3.6% | +6.6% | +17.2% | |
| Operating Margin | 4.8% | 2.6% | 4.7% | 2.6% | 1.9% | 2.1% | 6.0% | 1.4% | 1.3% | -1.9% | -2.1% | 4.1% | 0.5% |
| — | +20.2% | -22.0% | +82.7% | +49.6% | +213.3% | +388.8% | -66.2% | +156.7% | -213.8% | -5296.9% | +5388.3% | +5941.9% | |
| Net Margin | 0.0% | 5.8% | -2.9% | -0.6% | 6.4% | -2.6% | -3.8% | -5.6% | -3.6% | -7.0% | -2.9% | 1.3% | -1.8% |
| — | +326.5% | +23.0% | +88.7% | +279.4% | +63.3% | -29.7% | -528.0% | -98.4% | -303.7% | -8.5% | +159.2% | -35.7% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.0% | 1.5% | -0.7% | -0.2% | 1.7% | -0.8% | -1.2% | -1.6% | -1.0% | -1.9% | -0.8% | 0.3% | -0.5% |
| — | +285.4% | +37.7% | +90.1% | +265.2% | +58.4% | -46.2% | -569.8% | -121.3% | -302.2% | -7.3% | +153.3% | -34.5% | |
| ROA | 0.0% | 0.8% | -0.4% | -0.1% | 0.9% | -0.4% | -0.6% | -0.8% | -0.5% | -0.9% | -0.4% | 0.2% | -0.2% |
| — | +306.6% | +31.1% | +89.2% | +270.7% | +59.5% | -43.0% | -568.7% | -124.5% | -317.1% | -13.0% | +156.1% | -38.9% | |
| ROIC | 2.5% | 0.3% | 0.6% | 0.3% | 0.2% | 0.3% | 0.8% | 0.2% | 0.2% | -0.2% | -0.3% | 0.5% | 0.1% |
| — | +10.1% | -30.0% | +77.3% | +46.4% | +229.8% | +432.3% | -61.6% | +192.1% | -215.8% | -5308.5% | +4870.7% | +5810.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
ICU Medical, Inc.'s Debt/EBITDA ratio is 94.3x, up from 17.5x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 9.7% YoY to 2.34x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.66 | 0.61 | 0.66 | 0.64 | 0.66 | 0.81 | 0.84 | 0.81 | 0.82 | 0.82 | 0.80 | 0.82 | 0.81 |
| — | -24.7% | -21.5% | -20.8% | -20.3% | -1.3% | +4.1% | -0.9% | +1.1% | -1.1% | -3.3% | -5.4% | -2.6% | |
| Debt / EBITDA | 4.28 | 94.31 | 17.50 | 21.15 | 23.07 | 25.68 | 18.10 | 25.99 | 26.65 | 37.60 | 37.90 | 5.78 | 28.60 |
| — | +267.3% | -3.3% | -18.6% | -13.4% | -31.7% | -52.2% | +349.5% | -6.8% | +41.2% | +23.7% | -80.6% | +8.9% | |
| Current Ratio | 2.36 | 2.34 | 2.36 | 2.45 | 2.44 | 2.59 | 2.59 | 2.29 | 2.41 | 2.61 | 2.53 | 2.62 | 2.56 |
| — | -9.7% | -9.0% | +7.0% | +1.2% | -0.6% | +2.4% | -12.5% | -5.7% | -0.3% | +1.3% | +7.0% | +5.2% | |
| Quick Ratio | 1.13 | 1.17 | 1.13 | 1.19 | 1.17 | 1.52 | 1.54 | 1.03 | 1.08 | 1.09 | 1.06 | 0.98 | 0.96 |
| — | -22.7% | -27.0% | +15.2% | +8.1% | +39.8% | +45.6% | +5.2% | +12.9% | +8.8% | -2.9% | -16.1% | -22.4% | |
| Interest Coverage | 1.03 | 0.82 | 0.26 | 0.80 | 2.46 | 0.49 | 1.31 | 0.34 | 0.27 | -0.39 | -0.37 | 0.45 | 0.11 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying ICUI stock.
ICU Medical, Inc.'s current P/E is 4186.1x. The average P/E over the last 2 quarters is 25.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
ICU Medical, Inc.'s current operating margin is 4.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking ICU Medical, Inc.'s business trajectory between earnings reports.